• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

他汀类药物、钙通道阻滞剂和β受体阻滞剂治疗可能会降低台湾老年2型糖尿病患者的结核病感染发生率。

Statin, calcium channel blocker and Beta blocker therapy may decrease the incidence of tuberculosis infection in elderly Taiwanese patients with type 2 diabetes.

作者信息

Lee Mei-Yueh, Lin Kun-Der, Hsu Wei-Hao, Chang Hsiu-Ling, Yang Yi-Hsin, Hsiao Pi-Jung, Shin Shyi-Jang

机构信息

Department of Internal Medicine, Kaohsiung Municipal Hsiao-Kang Hospital, Kaohsiung 812, Taiwan.

Division of Endocrinology and Metabolism, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung 807, Taiwan.

出版信息

Int J Mol Sci. 2015 May 18;16(5):11369-84. doi: 10.3390/ijms160511369.

DOI:10.3390/ijms160511369
PMID:25993300
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4463705/
Abstract

BACKGROUND

It is well known that diabetes mellitus impairs immunity and therefore is an independent risk factor for tuberculosis. However, the influence of associated metabolic factors, such as hypertension, dyslipidemia and gout has yet to be confirmed. This study aimed to investigate whether the strong association between tuberculosis and diabetes mellitus is independent from the influence of hypertension and dyslipidemia, and its treatment in elderly Taiwanese patients.

METHODS

A total of 27,958 patients aged more than 65 years were identified from the National Health Insurance Research Database (NIHRD) in 1997 and were followed from 1998 to 2009. The demographic characteristics between the patients with and without diabetes were analyzed using the χ2 test. A total of 13,981 patients with type 2 diabetes were included in this study. Cox proportional hazard regression models were used to determine the independent effects of diabetes on the risk of tuberculosis.

RESULTS

After adjusting for age, sex, other co-morbidities and medications, calcium channel blocker, beta blocker and statin users had a lower independent association, with risk ratios of 0.76 (95% CI, 0.58-0.98), 0.72 (95% CI, 0.58-0.91) and 0.76 (95% CI, 0.60-0.97), respectively.

CONCLUSION

Calcium channel blocker, beta blocker and statin therapy may decrease the incidence of tuberculosis infection in elderly Taiwanese patients with type 2 diabetes.

摘要

背景

众所周知,糖尿病会损害免疫力,因此是结核病的独立危险因素。然而,高血压、血脂异常和痛风等相关代谢因素的影响尚未得到证实。本研究旨在调查结核病与糖尿病之间的强关联是否独立于高血压和血脂异常的影响,以及其在台湾老年患者中的治疗情况。

方法

1997年从国民健康保险研究数据库(NIHRD)中识别出总共27958名年龄超过65岁的患者,并从1998年至2009年进行随访。使用χ2检验分析有糖尿病和无糖尿病患者之间的人口统计学特征。本研究共纳入13981名2型糖尿病患者。采用Cox比例风险回归模型确定糖尿病对结核病风险的独立影响。

结果

在调整年龄、性别、其他合并症和药物后,使用钙通道阻滞剂、β受体阻滞剂和他汀类药物的患者有较低的独立关联,风险比分别为0.76(95%CI,0.58 - 0.98)、0.72(95%CI,0.58 - 0.91)和0.76(95%CI,0.60 - 0.97)。

结论

钙通道阻滞剂、β受体阻滞剂和他汀类药物治疗可能会降低台湾老年2型糖尿病患者的结核病感染发生率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/946a/4463705/49601182aaea/ijms-16-11369-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/946a/4463705/f472749942de/ijms-16-11369-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/946a/4463705/49601182aaea/ijms-16-11369-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/946a/4463705/f472749942de/ijms-16-11369-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/946a/4463705/49601182aaea/ijms-16-11369-g002.jpg

相似文献

1
Statin, calcium channel blocker and Beta blocker therapy may decrease the incidence of tuberculosis infection in elderly Taiwanese patients with type 2 diabetes.他汀类药物、钙通道阻滞剂和β受体阻滞剂治疗可能会降低台湾老年2型糖尿病患者的结核病感染发生率。
Int J Mol Sci. 2015 May 18;16(5):11369-84. doi: 10.3390/ijms160511369.
2
The development of new-onset type 2 diabetes associated with choosing a calcium channel blocker compared to a diuretic or beta-blocker.与选择利尿剂或β受体阻滞剂相比,选择钙通道阻滞剂与新发2型糖尿病的发生有关。
Curr Med Res Opin. 2007 Jun;23(6):1239-44. doi: 10.1185/030079907X188044. Epub 2007 Apr 23.
3
Prevention of cardiovascular events with calcium channel blocker-based combination therapies in patients with hypertension: a randomized controlled trial.钙通道阻滞剂为基础的联合治疗预防高血压患者心血管事件的随机对照试验。
J Hypertens. 2011 Aug;29(8):1649-59. doi: 10.1097/HJH.0b013e328348345d.
4
Association between cardiovascular outcomes and antihypertensive drug treatment in older women.老年女性心血管结局与降压药物治疗之间的关联
JAMA. 2004 Dec 15;292(23):2849-59. doi: 10.1001/jama.292.23.2849.
5
Beta-blockers and cardiovascular outcomes in dialysis patients: a cohort study in Ontario, Canada.β受体阻滞剂在透析患者中的心血管结局:加拿大安大略省的队列研究。
Nephrol Dial Transplant. 2012 Apr;27(4):1591-8. doi: 10.1093/ndt/gfr460. Epub 2011 Aug 26.
6
Antihypertensive Drugs and Diabetic Retinopathy in Patients with Type 2 Diabetes.2型糖尿病患者的抗高血压药物与糖尿病视网膜病变
Ophthalmologica. 2016;235(2):87-96. doi: 10.1159/000441958. Epub 2015 Dec 23.
7
Statin use and incident dementia: a nationwide cohort study of Taiwan.他汀类药物的使用与新发痴呆症:台湾的一项全国性队列研究。
Int J Cardiol. 2014 May 1;173(2):305-10. doi: 10.1016/j.ijcard.2014.03.018. Epub 2014 Mar 15.
8
Statins and new-onset diabetes: a retrospective longitudinal cohort study.他汀类药物与新发糖尿病:一项回顾性纵向队列研究。
Clin Ther. 2012 Sep;34(9):1977-83. doi: 10.1016/j.clinthera.2012.08.004. Epub 2012 Aug 30.
9
Angiotensin II receptor blocker-based therapy in Japanese elderly, high-risk, hypertensive patients.血管紧张素 II 受体阻滞剂在日本老年、高危、高血压患者中的应用。
Am J Med. 2012 Oct;125(10):981-90. doi: 10.1016/j.amjmed.2011.12.010. Epub 2012 Apr 14.
10
Statin Use and the Risk for Incident Diabetes Mellitus in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention: A Population-Based Retrospective Cohort Study in Taiwan.他汀类药物的使用与经皮冠状动脉介入治疗后急性冠状动脉综合征患者新发糖尿病的风险:台湾一项基于人群的回顾性队列研究。
Can J Diabetes. 2016 Jun;40(3):264-9. doi: 10.1016/j.jcjd.2015.12.006. Epub 2016 Mar 15.

引用本文的文献

1
Impact of COVID-19 pandemic responses on tuberculosis incidence: insights from Shantou, China.新冠疫情应对措施对结核病发病率的影响:来自中国汕头的观察。
BMC Public Health. 2024 May 30;24(1):1454. doi: 10.1186/s12889-024-18956-2.
2
Association between statin use and tuberculosis risk in patients with bronchiectasis: a retrospective population-based cohort study in Taiwan.他汀类药物使用与支气管扩张症患者结核病风险的关联:台湾基于人群的回顾性队列研究。
BMJ Open Respir Res. 2024 Feb 22;11(1):e002077. doi: 10.1136/bmjresp-2023-002077.
3
Effect of calcium-channel blockers on the risk of active tuberculosis and mortality: systematic review and meta-analysis.

本文引用的文献

1
Acceleration of tuberculosis treatment by adjunctive therapy with verapamil as an efflux inhibitor.维拉帕米作为外排抑制剂辅助治疗加速结核病治疗。
Am J Respir Crit Care Med. 2013 Sep 1;188(5):600-7. doi: 10.1164/rccm.201304-0650OC.
2
The structure of the Mycobacterium smegmatis trehalose synthase reveals an unusual active site configuration and acarbose-binding mode.耻垢分枝杆菌海藻糖合酶的结构揭示了一种不寻常的活性位点构象和阿卡波糖结合模式。
Glycobiology. 2013 Sep;23(9):1075-83. doi: 10.1093/glycob/cwt044. Epub 2013 Jun 4.
3
Diabetes and tuberculosis: a review of the role of optimal glycemic control.
钙通道阻滞剂对活动性肺结核风险及死亡率的影响:系统评价与荟萃分析
Front Pharmacol. 2024 Jan 18;15:1298919. doi: 10.3389/fphar.2024.1298919. eCollection 2024.
4
Host-directed therapy against mycobacterium tuberculosis infections with diabetes mellitus.抗结核分枝杆菌感染的宿主定向治疗伴糖尿病。
Front Immunol. 2024 Jan 8;14:1305325. doi: 10.3389/fimmu.2023.1305325. eCollection 2023.
5
Repositioning of HMG-CoA Reductase Inhibitors as Adjuvants in the Modulation of Efflux Pump-Mediated Bacterial and Tumor Resistance.将HMG-CoA还原酶抑制剂重新定位为外排泵介导的细菌和肿瘤耐药性调节佐剂。
Antibiotics (Basel). 2023 Sep 20;12(9):1468. doi: 10.3390/antibiotics12091468.
6
A united model for diagnosing pulmonary tuberculosis with random forest and artificial neural network.一种用于诊断肺结核的随机森林和人工神经网络联合模型。
Front Genet. 2023 Mar 9;14:1094099. doi: 10.3389/fgene.2023.1094099. eCollection 2023.
7
Host-directed therapies in pulmonary tuberculosis: Updates on anti-inflammatory drugs.肺结核的宿主导向疗法:抗炎药物的最新进展
Front Med (Lausanne). 2022 Sep 23;9:970408. doi: 10.3389/fmed.2022.970408. eCollection 2022.
8
Incidence and prevalence of pulmonary tuberculosis among patients with type 2 diabetes mellitus: a systematic review and meta-analysis.2 型糖尿病患者中肺结核的发病率和患病率:系统评价和荟萃分析。
Ann Med. 2022 Dec;54(1):1657-1666. doi: 10.1080/07853890.2022.2085318.
9
Further insights into to the role of statins against active tuberculosis: systematic review and meta-analysis.对他汀类药物抗活动性肺结核作用的进一步见解:系统评价与荟萃分析。
Infez Med. 2022 Jun 1;30(2):194-203. doi: 10.53854/liim-3002-4. eCollection 2022.
10
Recent Advances in Host-Directed Therapies for Tuberculosis and Malaria.结核病和疟疾的宿主导向治疗新进展。
Front Cell Infect Microbiol. 2022 May 20;12:905278. doi: 10.3389/fcimb.2022.905278. eCollection 2022.
糖尿病与结核病:最佳血糖控制作用的综述
J Diabetes Metab Disord. 2012 Dec 20;11(1):28. doi: 10.1186/2251-6581-11-28.
4
Is vitamin D status a predictor glycaemic regulation and cardiac complication in type 2 diabetes mellitus patients?维生素D状态是2型糖尿病患者血糖调节和心脏并发症的预测指标吗?
Diabetes Metab Syndr. 2012 Jan-Mar;6(1):28-31. doi: 10.1016/j.dsx.2012.05.007. Epub 2012 Jun 6.
5
The immune system in the aging human.衰老人体中的免疫系统。
Immunol Res. 2012 Sep;53(1-3):235-50. doi: 10.1007/s12026-012-8289-3.
6
Risk of tuberculosis among people with diabetes mellitus: an Australian nationwide cohort study.糖尿病患者患结核病的风险:一项澳大利亚全国性队列研究。
BMJ Open. 2012 Feb 13;2(1):e000666. doi: 10.1136/bmjopen-2011-000666. Print 2012.
7
Completeness and timeliness of tuberculosis notification in Taiwan.台湾结核病通报的完整性和及时性。
BMC Public Health. 2011 Dec 12;11:915. doi: 10.1186/1471-2458-11-915.
8
Pathogens and atherosclerosis: update on the potential contribution of multiple infectious organisms to the pathogenesis of atherosclerosis.病原体与动脉粥样硬化:多种感染病原体在动脉粥样硬化发病机制中的潜在作用的最新研究进展。
Thromb Haemost. 2011 Nov;106(5):858-67. doi: 10.1160/TH11-06-0392. Epub 2011 Oct 20.
9
Vitamin D and diabetes: its importance for beta cell and immune function.维生素 D 与糖尿病:对胰岛β细胞和免疫功能的重要性。
Mol Cell Endocrinol. 2011 Dec 5;347(1-2):106-20. doi: 10.1016/j.mce.2011.08.016. Epub 2011 Aug 26.
10
The impact of diabetes on tuberculosis treatment outcomes: a systematic review.糖尿病对结核病治疗结局的影响:系统评价。
BMC Med. 2011 Jul 1;9:81. doi: 10.1186/1741-7015-9-81.